Lilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Eli Lilly & Co. is tapping the U.S. investment-grade bond market on Monday to help finance its roughly $2.5 billion purchase ...
Eli Lilly has announced results from the VIVID-2 open-label extension study, showing that most patients with moderately to ...
17h
Barchart on MSNBank of America: 3 Stocks to Buy for Future Stock Split PotentialDetailed price information for Meta Platforms Inc (META-Q) from The Globe and Mail including charting and trades.
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...
Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...
Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting event.
9h
India Today on MSNTrump suspends US Foreign Corruption Act; glimmer of hope for Gautam Adani?The potential impact of Trump’s suspension of Foreign Corrupt Practices Act (FCPA) enforcement is significant, particularly ...
MONTPELIER - Chase Pickel is still a freshman for U-32, but the second-generation Raider displayed his mastery between the ...
The asset-backed primary is bracing for another busy week after 16 issuers priced more than US$14.8bn last week, while the RMBS sector is expecting a number of jumbo deals. Over in the ECM, primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results